Category: New products
-
Trial Testing Multi-Company Covid-19 Therapy
A clinical trial already underway is expanding to test a combination of two synthetic antibodies from different companies as a treatment for Covid-19 infections.
-
Food Allergy Biotech Raises $40M in New Funds
A biotechnology company designing proteins in food products and therapies for people with food allergies is raising $40 million in its second venture round.
-
Antibody Therapy Shown to Prevent Covid-19 Disease
Clinical trial results show a combination of synthetic antibodies designed to treat Covid-19 infections can also prevent contracting the disease.
-
Covid-19 Vaccine Shown Active Against Variants
Moderna Inc., developer of a vaccine to prevent Covid-19 disease, says lab test results show antibodies from the vaccine neutralize two recently found viral mutations.
-
AI Harnessed for Patient Monitoring Analytics
New software is being trialed that captures vital signs and uses artificial intelligence to predict and display health trajectories for the patient.
-
Essay – Find the Missing Vaccine Doses
Biden’s vaccine distribution team needs to find those doses, and fast, before their shelf life expires.
-
CubeSats to Test Satellite Group Signaling
A university robotics lab built three small space satellites for NASA to test radio transmissions in autonomous groups or swarms for more sophisticated future missions.
-
Monthly HIV Drug Combo Approved by FDA
The Food and Drug Administration approved a drug regimen given once a month to control HIV infections, to replace daily antiretroviral medications.
-
Antibodies Prevent Covid-19 Symptoms in Long-Term Care
A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower risk of getting symptomatic Covid-19 infections.
-
Crispr Heart Disease Biotech Raises $94M in New Funds
A company applying Crispr gene-editing technology to treat inherited heart disease is raising $94 million in its second venture funding round.